NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/15/2022
Back to search
Official data from USPTO
Q MOLECULE TO CURE. FAST.
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
11/15/2022
Classification
Registered
Trademark type
Combined
Nice classes
39, 40, 42
Filing date
03/04/2021
Registration date
11/15/2022
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/15/2022
Last transaction
11/15/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
3
Owner type
99
Owner location
Ruddington, Nottingham, GB
Examiner
GIPSOV, MARYNA K
Law office
N90
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of two light grey squares next to each other. The square on the left contains a semi-circular navy blue curved line with light blue molecules floating from the semi-circle and the navy blue letter "Q" overlayed on top of the design. The square on the right contains a word-stacked stylization of the black wording "MOLECULE" on top of the black wording "TO CURE", both of which are on top of the black wording "FAST". All instances of the color white represent a background and are not claimed as a feature of the mark.
Holders and representatives
Holders
Quotient Sciences Limited
Representatives
Amy Cohen Heller LAW OFFICE OF AMY COHEN HELLER, LLC
Technical classification
Nice Classes
Class 39Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 39
Contract packaging services in the nature of packaging and labeling of pharmaceutical and biopharmaceuticals for distribution on behalf of third parties; packaging and labeling of products for otherscontract packaging services in the nature of merchandise packaging for others; storage serviceswarehousing and temperature controlled storage of goods for others; transportation logistics servicesarranging transportation of goods for others; packaging articles to the order and specification of others; packaging of pharmaceuticalbiopharmaceutical and clinical supplies and materialscontract packaging services in the nature of pharmaceuticalbiopharmaceutical and clinical supplies and materials packaging for others
Class 40
Custom manufacture of pharmaceuticals and biopharmaceuticals; custom manufacture of pharmaceuticals and biopharmaceuticals for clinical trial purposes; manufacturing services for clinical trialsmanufacture of pharmaceuticals and biopharmaceuticals to order and/or specification of others; providing information about the results of clinical trials for pharmaceutical and biopharmaceutical productsproviding technical information in the field of pharmaceutical and biopharmaceutical manufacturing and testing
Class 42
Clinical research in the field of pharmacology and medical research; clinical trials for others; conducting clinical trials for others; conducting clinical trials for others in the field of pharmaceutical and biopharmaceutical products; pharmaceutical and biopharmaceutical research services; pharmaceutical and biopharmaceutical testing services; research relating to sciencescientific researchbasic and clinical research in the fields of pharmacologypharmaceuticals and biopharmaceuticals; analytical servicesevaluation and analysis of the efficacy of pharmaceutical and biopharmaceutical products and dosages in the nature of analysis and evaluation of pharmaceutical and biopharmaceutical products and dosages of others to determine conformity with certification standards and to assure compliance with industry standards; pharmaceutical and biopharmaceutical product evaluation; providing medical and scientific research information in the field of pharmaceuticalsbiopharmaceuticals and clinical trials; biological research; research and development of vaccines and medicines; pharmaceutical and biopharmaceutical drug development services; pharmaceutical and biopharmaceutical products development; pharmaceutical and biopharmaceutical formulation design and development servicesdevelopment of pharmaceutical and biopharmaceutical preparations and medicines; pre-formulation screening servicesconducting early evaluations in the field of new pharmaceutical and testinginspection and research of pharmaceuticals; conducting clinical trials for others for optimisation of pharmaceutical and biopharmaceutical formulations and dosage through clinical testing; development of pharmaceutical and biopharmaceutical preparations and medicinesresearch and development of vaccines and medicinesproduct research and developmentproduct development for othersresearch relating to medicinemedical researchbasic and clinical research in the field of pharmacology; consultancy relating to pharmaceutical and biopharmaceutical testing and screening programs in particular testinginspection and research of pharmaceuticals and biopharmaceuticals; consultancy in the field of pharmacology; clinical pharmacologytechnical researchtesting and consulting in the field of pharmaceutical and biopharmaceutical studies; laboratory research services relating to pharmaceuticals
Publications
History of USPTO decisions and trademark events.
23 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
11/15/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/30/2022
PUBO
PUBLISHED FOR OPPOSITION
08/30/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/10/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/26/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/25/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/25/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/25/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/13/2022
GNRT
NON-FINAL ACTION E-MAILED
06/13/2022
CNRT
NON-FINAL ACTION WRITTEN
06/13/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/09/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/09/2022
ALIE
ASSIGNED TO LIE
04/29/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/26/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/29/2021
GNRT
NON-FINAL ACTION E-MAILED
10/29/2021
CNRT
NON-FINAL ACTION WRITTEN
10/29/2021
DOCK
ASSIGNED TO EXAMINER
09/27/2021
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
06/04/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/03/2021
NWAP
NEW APPLICATION ENTERED
03/08/2021
Continuous trademark protection
Get notified about every new filing that threatens Q MOLECULE TO CURE. FAST. or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.